135 related articles for article (PubMed ID: 7666904)
1. Is the use of t-PA as compared with streptokinase cost effective?
Rose EA
N Engl J Med; 1995 Oct; 333(15):1009; author reply 1010. PubMed ID: 7666904
[No Abstract] [Full Text] [Related]
2. Is the use of t-PA as compared with streptokinase cost effective?
Armentano R; Favaloro RG
N Engl J Med; 1995 Oct; 333(15):1009-10. PubMed ID: 7666905
[No Abstract] [Full Text] [Related]
3. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
Kent DM; Vijan S; Hayward RA; Griffith JL; Beshansky JR; Selker HP
J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
[TBL] [Abstract][Full Text] [Related]
5. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
Massel D
Can J Cardiol; 1999 Feb; 15(2):173-9. PubMed ID: 10079776
[TBL] [Abstract][Full Text] [Related]
6. [Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?].
Gulba DC
Internist (Berl); 1992 May; 33(5):364-5. PubMed ID: 1612871
[No Abstract] [Full Text] [Related]
7. [Thrombolytic therapy].
de Gaetano G; Donati MB; Gensini GF; Restagno C
Recenti Prog Med; 1993 Sep; 84(9):581-5. PubMed ID: 8210621
[No Abstract] [Full Text] [Related]
8. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
Lorenzoni R; Fattore G; Gensini G
G Ital Cardiol; 1997 Jul; 27(7):721-6. PubMed ID: 9303862
[TBL] [Abstract][Full Text] [Related]
9. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
Goel V; Naylor CD
Can J Cardiol; 1992; 8(1):31-8. PubMed ID: 1617509
[TBL] [Abstract][Full Text] [Related]
10. Myocardial infarction, thrombolytic therapy, and economics.
Shander D
Clin Cardiol; 1993 Nov; 16(11):845. PubMed ID: 8269667
[No Abstract] [Full Text] [Related]
11. Cost, uncertainty, and doctors' decisions. The case of thrombolytic therapy.
Lessler DS; Avins AL
Arch Intern Med; 1992 Aug; 152(8):1665-72. PubMed ID: 1497400
[TBL] [Abstract][Full Text] [Related]
12. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients].
Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B
Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic therapy for acute myocardial infarction: GUSTO criticized.
Friedman HS
N Engl J Med; 1994 Feb; 330(7):504; author reply 505-6. PubMed ID: 8289861
[No Abstract] [Full Text] [Related]
14. Safe use of thrombolysis in the elderly.
Wittry MD; Thornton TA; Chaitman BR
Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
[TBL] [Abstract][Full Text] [Related]
16. [Tissue plasminogen activator is the best thrombolytic agent].
Bates E
Arq Bras Cardiol; 1994 Jul; 63(1):57-8. PubMed ID: 7857215
[No Abstract] [Full Text] [Related]
17. Cost effectiveness of tissue plasminogen activator.
Lee TH
N Engl J Med; 1995 May; 332(21):1443-4. PubMed ID: 7723804
[No Abstract] [Full Text] [Related]
18. Thrombolytic therapy for myocardial infarction.
Guerci AD
Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282
[TBL] [Abstract][Full Text] [Related]
19. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
Naylor CD; Bronskill S; Goel V
Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
